Other
Risk-free rate
West Pharmaceutical Services Risk-free rate decreased by 17.8% to 3.7% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.8%, from 4.5% to 3.7%.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Changes in this rate reflect broader macroeconomic interest rate environments and impact option valuation.
Detailed definition
The interest rate on risk-free government securities used as an input in valuation models for employee stock options. Th...
Peer comparison
Standard disclosure in the footnotes of financial statements for all public companies.
Metric ID:
other_share_based_compensation_arrangement_by_share_base_87d3a4Historical Data
5 periods
| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | 1.8% | 4.1% | 4.3% | 4.5% | 3.7% |
| QoQ Change | — | +127.8% | +4.9% | +4.7% | -17.8% |
| YoY Change | — | +127.8% | +4.9% | +4.7% | -17.8% |
Range1.8% – 4.5%
CAGR+105.6%
Avg YoY Growth+29.9%
Median YoY Growth+4.8%
Risk-free rate at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's risk-free rate?
- West Pharmaceutical Services (WST) reported risk-free rate of 3.7% in Q1 2026.
- How has West Pharmaceutical Services's risk-free rate changed year-over-year?
- West Pharmaceutical Services's risk-free rate decreased by 17.8% year-over-year, from 4.5% to 3.7%.
- What does risk-free rate mean?
- The interest rate used to value employee stock options based on the expected life of the award.